DALLAS, Texas, June 30, 2011 /PRNewswire/ --
The ' Lung Cancer Surgery Market (Devices & Treatment Outlook) - Trends & Challenges (2010 - 2015)" analyzes the lung cancer market by types of surgical procedures and surgical devices and studies the market dynamics of North America, Europe and ROW.
Browse about 96 market data tables and in-depth TOC on Lung Cancer Surgery Market (Devices & Treatment Outlook) -Trends & Challenges (2010 -2015).
Early buyers will receive 10% customization on reports.
Lung cancer is the most common type of cancer globally. According to WHO, lung cancer is expected to be more prominent in the underdeveloped world due to an increase in the use of tobacco products; tobacco is the primary cause of around 80% of all lung cancers. Global incidence of lung cancer was 1,608,055 in 2008 with the developing countries accounting for a major share (55%), 1,694,277 new cases were recorded in 2010 with 1,934,467, 2,213,561, and 2,530,820 as the predicted new cases for the years 2015, 2020, and 2025 respectively.
The lung cancer surgery market is expected to grow at a CAGR of 4.9% during the study period (2010-2015). Thoracotomy is the most widely used surgical procedure for lung cancer treatment; accounting for about 74% of all surgical interventions. The market for lung cancer surgeries was valued at $